Tan, W., Ng, Q. S., Lim, C., Tan, E. H., Toh, C. K., Ang, M., . . . Lim, D. W. (2018). Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases. BMC Cancer.
Chicago Style aipamenaTan, Wan-Ling, et al. "Correction To: Influence of Afatinib Dose On Outcomes of Advanced EGFR-mutant NSCLC Patients With Brain Metastases." BMC Cancer 2018.
MLA aipamenaTan, Wan-Ling, et al. "Correction To: Influence of Afatinib Dose On Outcomes of Advanced EGFR-mutant NSCLC Patients With Brain Metastases." BMC Cancer 2018.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.